Evidence map›Paper›PMID 39301511›Full record

ArticleFrontiers in toxicology2024

Inhibitory effects of NaF on mitochondrial energy generation in human platelets

Tetsuhiro Tsujino, Tomoni Kasahara, Hideo Kawabata, Taisuke Watanabe, Koji Nishiyama, Yutaka Kitamura, Takao Watanabe, Hajime Okudera, Tomoharu Mochizuki, Takashi Ushiki and 1 more

Abstract read
In one paragraph

Article in Frontiers in toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tetsuhiro TsujinoR&D Division, Tokyo Plastic Dental Society, Tokyo, Japan.
Tomoni KasaharaR&D Division, Tokyo Plastic Dental Society, Tokyo, Japan.
Hideo KawabataR&D Division, Tokyo Plastic Dental Society, Tokyo, Japan.
Taisuke WatanabeR&D Division, Tokyo Plastic Dental Society, Tokyo, Japan.
Koji NishiyamaR&D Division, Tokyo Plastic Dental Society, Tokyo, Japan.
Yutaka KitamuraR&D Division, Tokyo Plastic Dental Society, Tokyo, Japan.
Takao WatanabeR&D Division, Tokyo Plastic Dental Society, Tokyo, Japan.
Hajime OkuderaR&D Division, Tokyo Plastic Dental Society, Tokyo, Japan.
Tomoharu MochizukiDepartment of Orthopaedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Takashi UshikiDivision of Hematology and Oncology, Graduate School of Health Sciences, Niigata University, Niigata, Japan.
Tomoyuki KawaseDivision of Oral Bioengineering, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: fluoride is a beneficial ion that has been used in various fields, from industrial products to therapeutics. However, due to its narrow therapeutic index, fluoride sometimes acts as a toxic agent at relatively higher concentrations in the human body. Based on the interest in genetic stability, its cytotoxic effects have been investigated mainly in nucleated, adherent cells, such as fibroblasts. However, the sensitivity of blood cells, especially anucleate platelets, to fluoride is poorly understood. To fill this gap in the literature, we investigated the effects of relatively low levels of fluoride on platelet energy metabolism, function, and viability. Methods: Platelet-rich plasma (PRP) was prepared from 15 non-smoking healthy male adults (age: 28-63) and treated with NaF (0.5 or 1.0 mM) in microtubes for up to 3 days. Platelet function was evaluated based on aggregation and adhesion activities. Platelet energy metabolism was evaluated based on intracellular ATP levels, extracellular lactate levels, and respiration activities. The mitochondrial membrane potential (Em) and localization of reactive oxygen species (ROS) were visualized using cytochemical methods. Platelet viability was evaluated by cell counting and tetrazolium reduction. Result: NaF (1 mM) significantly reduced platelet viability and inhibited functions. Behind these phenomena, NaF substantially decreased mitochondrial Em and increased ROS production along with significant decreases in oxygen consumption and ATP levels. Simultaneously, NaF increased the lactate levels. Although not statistically significant, similar effects were observed at 0.5 mM NaF. Conclusion: At relatively low levels, NaF has the potential to attenuate platelet function probably primarily through the inhibition of mitochondrial energy generation. Cytotoxicity may be directly related to ROS production. These findings suggest that when used topically, for example, for caries prevention in the oral cavity, NaF could interfere with wound healing and tissue regeneration by endogenous and exogenously added platelets in the form of PRP.

Indexed as

adhesionaggregationATPfluorideplateletsrespiration

Identifiers

PMID39301511
PMCPMC11410780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.